Your session is about to expire
← Back to Search
This trial will study whether delivering exposure and response prevention therapy to women during different phases in their menstrual cycle affects the success of the therapy and the women's OCD symptoms.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- Women who do not have regular periods will be excluded.You use birth control that affects your menstrual cycle or have reached menopause.You have a mental health condition that could make it more risky for you to participate in the study or could affect the study outcomes.You have OCD that is moderate or severe in intensity.You have a medical or neurological condition that would make it unsafe for you to participate in the entire study.You are currently receiving mental health counseling or therapy.You have been diagnosed with OCD according to the DSM-5 guidelines.You must be able to take a break from your current treatment.You have had thoughts of hurting yourself or have tried to harm yourself recently.
- Group 1: Active Comparator
- Group 2: Experimental 1
- Group 3: Experimental 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants currently being sought for this research study?
"Affirmative. Clinicaltrials.gov data attests to the active recruitment period of this study, which was initially published on June 15th 2022 and revised on July 7th 2022. This medical trial requires 120 participants from 2 sites for its completion."
Who can partake in the experiment, and what criteria must they meet?
"This medical trial is recruiting 120 subjects, aged 18 to 45 years old and diagnosed with OCD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Women must be menstruating regularly, participants need not have taken psychotropic drugs in the past 12 weeks, exhibit moderate or greater severity symptoms at entry point and agree to a treatment free period. In addition willing participants must provide written informed consent after being briefed on study procedures."
How many subjects are enrolled in this clinical experiment?
"Affirmative. The clinical trial is recruiting according to the data listed on clinicaltrials.gov, which was first posted on June 15th 2022 and has been modified most recently as of July 7th 2022. This medical study requires 120 volunteers between two sites."
Does this clinical trial allow for participation from octogenarians?
"The eligibility criteria for this clinical trial specifies that participants must be between 18 and 45 years old. In addition, there are 3 studies intended to involve minors and a further 15 specifically targeted at seniors over 65."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends